Indian Insurers Show Mixed March Performance

Life Insurers Face Retail Challenges Amid Overall Growth

Life insurers reported overall premium growth in March, but retail policy sales varied significantly. Axis Max Life Insurance saw its premium income rise 11% year-on-year, with retail APE up 7%. However, ICICI Prudential Life Insurance's overall premiums surged 47%, supported by a 55% increase in total APE, yet its retail APE unexpectedly declined by 1%. This contrast suggests potential shifts in product mix or sales strategies where overall growth doesn't always mean more individual policies.

General and Health Insurance Sectors Post Strong Gains

General and health insurance sectors, however, showed strong and steady growth. ICICI Lombard General Insurance led the pack, with gross direct premium income up 21% year-on-year, far exceeding the industry's approximate 8% growth. In the health sector, Niva Bupa Health Insurance reported a 37% premium increase, significantly outpacing the segment's 22% average growth. Star Health and Allied Insurance grew 16%, which was below the segment average.

Sector Growth and Future Outlook

India's non-life insurance industry grew 8.78% year-on-year in March, reaching about ₹28,922 crore. Standalone health insurers were key drivers with 21.93% growth. For the full fiscal year 2025-26, the general insurance sector saw premiums rise 9.3% to around ₹3.36 trillion. Looking ahead, Swiss Re forecasts India's insurance market will grow 6.9% annually from 2026-2030, outpacing global peers due to strong economic conditions and rising consumer demand.

Retail Headwinds and Competitive Pressures

Within life insurance, ICICI Prudential's drop in retail APE is a concern, potentially pointing to higher customer acquisition costs or difficulty attracting new individual clients. In health insurance, Star Health's 16% growth lagged the segment's 22% average, suggesting it's losing pace to rivals like Niva Bupa. Go Digit General Insurance's 10% growth also seemed moderate against leaders like ICICI Lombard. Insurers face new reporting standards (Ind AS) from April 1, 2026, which may bring integration challenges. Competition in general insurance is fierce, with private players gaining share. Morgan Stanley rates ICICI Lombard 'Equal Weight' due to growth assumptions amid this competition.

Positive Long-Term View

Analysts remain largely optimistic about the sector, citing India's economic strength and increasing insurance awareness. For ICICI Lombard General Insurance, analysts generally recommend 'Buy,' predicting over 20% potential upside, driven by strong market share gains in retail health and motor segments. However, ongoing intense competition is a noted factor.